Cathie Wood acquired 1.69 Million Arcturus Therapeutics Holdings shares worth $45.7 Million. That's 0.37% of their equity portfolio (47th largest holding). The investor owns 6.45% of the outstanding Arcturus Therapeutics Holdings stock. The first Arcturus Therapeutics Holdings trade was made in Q4 2019. Since then Cathie Wood bought shares five more times and sold shares on twelve occasions. The investor's estimated purchase price is $65.9 Million, resulting in a loss of 31%.